Moderna and BioNTech shares fall after Senate committee vote RFK Jr.

Published 04/02/2025, 16:40
©  Reuters

Investing.com -- Moderna (NASDAQ: NASDAQ:MRNA) stock declined 4.9% and BioNTech SE (NASDAQ: NASDAQ:BNTX) shares fell 1.5% following the Senate Finance Committee’s vote to advance Robert F. Kennedy Jr.’s nomination for Secretary of Health and Human Services to the full Senate.

The movement in stock prices comes amid concerns from health groups, Democrats, and some Republicans regarding Kennedy’s stance on vaccines. Kennedy has been a prominent figure in the anti-vaccine movement, raising doubts about vaccine safety and efficacy, despite his denial of the anti-vaccine label. His potential confirmation as head of the department that oversees the FDA and healthcare programs has sparked unease among investors in vaccine manufacturers.

The Senate Committee on Finance’s decision on Tuesday to support Kennedy’s nomination has led to speculation about the future of vaccine policies in the United States. If confirmed, Kennedy would be responsible for an agency that manages over $3 trillion in healthcare spending and provides health insurance to more than 140 million Americans.

Republican committee member Bill Cassidy, a medical doctor, was a pivotal vote after expressing his struggle with the decision during a confirmation hearing. Despite opposition, Cassidy ultimately supported Kennedy, citing commitments from the administration on health and policy issues.

Kennedy’s confirmation requires the support of at least 50 senators, with Vice President JD Vance potentially casting a tie-breaking vote. The Republican-controlled Senate has yet to reject any of Trump’s nominees, including the recent narrow confirmation of defense secretary Pete Hegseth, which required Vance’s intervention.

The decline in Moderna and BioNTech stock reflects investor apprehension about the potential impact of Kennedy’s confirmation on the vaccine industry. The market’s response indicates concerns over possible changes in vaccine policies and regulations that could affect these companies’ operations and revenue.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.